NHS Thurrock CCG - Statutory Accounts - 1-Apr-22 to 30-Jun-22
Notes to the financial statements
The NHS Clinical Commissioning Group as Lessee
A right-of-use asset and a corresponding lease liability are recognised at commencement of the lease.
The lease liability is initially measured at the present value of the future lease payments, discounted by using the rate implicit in the
lease. If this rate cannot be readily determined, the prescribed HM Treasury discount rates are used as the incremental borrowing
rate to discount future lease payments.
The HM Treasury incremental borrowing rate of 0.95% is applied for leases commencing, transitioning or being remeasured in the
2022 calendar year under IFRS 16.
Lease payments included in the measurement of the lease liability comprise
-Fixed payments;
-Variable lease payments dependent on an index or rate, initially measured using the index or rate at commencement;
-The amount expected to be payable under residual value guarantees;
-The exercise price of purchase options, if it is reasonably certain the option will be exercised; and
-Payments of penalties for terminating the lease, if the lease term reflects the exercise of an option to terminate the lease.
Variable rents that do not depend on an index or rate are not included in the measurement the lease liability and are recognised as
an expense in the period in which the event or condition that triggers those payments occurs.
The lease liability is subsequently measured by increasing the carrying amount for interest incurred using the effective interest
method and decreasing the carrying amount to reflect the lease payments made. The lease liability is remeasured, with a
corresponding adjustment to the right-of-use asset, to reflect any reassessment of or modification made to the lease.
The right-of-use asset is initially measured at an amount equal to the initial lease liability adjusted for any lease prepayments or
incentives, initial direct costs or an estimate of any dismantling, removal or restoring costs relating to either restoring the location of
the asset or restoring the underlying asset itself, unless costs are incurred to produce inventories.
The subsequent measurement of the right-of-use asset is consistent with the principles for subsequent measurement of property,
plant and equipment. Accordingly, right-of-use assets, that are held for their service potential and are in use, are subsequently
measured at their current value in existing use.
Right-of-use assets for leases that are low value or short term and for which current value in use is not expected to fluctuate
significantly due to changes in market prices and conditions are valued at depreciated historical cost as a proxy for current value in
Other than leases for assets under construction and investment property, the right-of-use asset is subsequently depreciated on a
straight-line basis over the shorter of the lease term or the useful life of the underlying asset. The right-of-use asset is tested for
impairment if there are any indicators of impairment and impairment losses are accounted for as described in the ‘Depreciation,
amortisation and impairments’ policy.
Peppercorn leases are defined as leases for which the consideration paid is nil or nominal (that is, significantly below market value).
Peppercorn leases are in the scope of IFRS 16 if they meet the definition of a lease in all aspects apart from containing
consideration.
For peppercorn leases a right-of-use asset is recognised and initially measured at current value in existing use. The lease liability is
measured in accordance with the above policy. Any difference between the carrying amount of the right-of-use asset and the lease
liability is recognised as income as required by IAS 20 as interpreted by the FReM.
Leases of low value assets (value when new less than £5,000) and short-term leases of 12 months or less are recognised as an
expense on a straight-line basis over the term of the lease.
1.10
Cash is cash in hand and deposits with any financial institution repayable without penalty on notice of not more than 24 hours. Cash
equivalents are investments that mature in 3 months or less from the date of acquisition and that are readily convertible to known
amounts of cash with insignificant risk of change in value.
In the Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and that
form an integral part of the clinical commissioning group’s cash management.
1.11
Provisions are recognised when the NHS clinical commissioning group has a present legal or constructive obligation as a result of a
past event, it is probable that the NHS clinical commissioning group will be required to settle the obligation, and a reliable estimate
can be made of the amount of the obligation. The amount recognised as a provision is the best estimate of the expenditure required
to settle the obligation at the end of the reporting period, taking into account the risks and uncertainties. Where a provision is
measured using the cash flows estimated to settle the obligation, its carrying amount is the present value of those cash flows using
HM Treasury’s discount rate as follows:
When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, the
receivable is recognised as an asset if it is virtually certain that reimbursements will be received and the amount of the receivable can
be measured reliably.
A restructuring provision is recognised when the NHS clinical commissioning group has developed a detailed formal plan for the
restructuring and has raised a valid expectation in those affected that it will carry out the restructuring by starting to implement the
plan or announcing its main features to those affected by it. The measurement of a restructuring provision includes only the direct
expenditures arising from the restructuring, which are those amounts that are both necessarily entailed by the restructuring and not
associated with on-going activities of the entity.